BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a partnership with Dante Labs, a global genetic testing and data analysis company specialized in whole genome sequencing and interpretation intended both for Direct To Consumers and larger scale Life Science industry projects. With the steps taken, Dante […]
DURHAM – BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding. This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati. The funding will accelerate BioSkryb’s product roadmap […]
Quality Immune Checkpoint Proteins Release by Beta Lifescience for the Month of January 2020 FIREFILED, N.J. — Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the company’s newly launched website. Immune checkpoints refer to […]
Track the health of cell cultures without removing them from the incubator The OLYMPUS Provi CM20 incubation monitoring system* provides quantitative data about the health of cell cultures while they are in the incubator. The system periodically scans the cultures, counts the number of cells, determines confluency and wirelessly communicates the data to a tablet […]
License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools DUBLIN, Ireland, and Ipswich MA, USA : ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs (NEB®), […]
genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system Lyon, France – genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic alliance with Merck, a leading science and technology company and leader in genome editing. In December 2018, genOway […]
SEATTLE — TwinStrand Biosciences™, a novel genetic sequencing technology company, today announced the close of $16 million in Series A funding, including $12 million in new capital. Madrona Venture Group led the investment with participation from Alexandria Venture Investments, Ridgeback Capital and Sahsen Ventures. The funding will be used to accelerate the company’s commercial pipeline, as well as to […]
BOULDER, Colo.— ArcherDX, Inc., a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has been appointed Chief Financial Officer. Mark Massaro, ArcherDX Chief Financial Officer “We are thrilled to welcome Mark to the ArcherDX team,” said Jason Myers, Chief Executive Officer. “Mark’s extensive […]
Advancements Expected to Accelerate Development of mRNA Therapeutics SAN DIEGO – TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United States Patent and Trademark Office has issued two new patents to the company. Both patents cover advancements in TriLink’s […]
MGI announced today that it has the market clearance for its G and T Series sequencers in Asia Pacific countries and Europe. Its DNBSEQ-T7, DNBSEQ-G400 and DNBSEQ-G50 sequencers are now cleared in European countries recognizing the CE-IVD mark and ready to position in clinical settings. The European IVD CE Mark approval opens up a wider global market […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
